logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

CICC’s Subsidiary Leads $103M Series B In Tumor Radiotherapy Start-up Allcure Medical

Jul 23, 2018

Life Science

Eastwood Bio-medical Canada Inc. (TSXV EBM)

Eastwood Bio-medical Canada Inc. Unaware of Any Material Change for Immediate Release

Jul 23, 2018

Life Science

Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China

Jul 23, 2018

Life Science

BeiGene Shows Off Strong Results from Checkpoint Inhibitor While Eying Potential Approval for BTK Inhibitor

Jul 23, 2018

Life Science

Long Hill Capital Closes $265 Million Second Fund for China Health Investments,長嶺資本完成中國醫療保健領域投資的第二支基金募集

Long Hill Capital Closes $265 Million Second Fund for China Health Investments

Jul 23, 2018

Life Science

Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year

Jul 20, 2018

Life Science

Kolon Life Science to Export $207 Million of Gene Therapy Treatment to China’s Hainan Province

Jul 20, 2018

Life Science

Shanghai Fosun Pharma Considering $500 Million IPO of Gland Pharma

Jul 20, 2018

Life Science

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

Jul 20, 2018

Life Science

中国朗煜资本全盘收购美国Alpine Immune Sciences公司GSNOR抑制剂资产,Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital

Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital

Jul 20, 2018

Life Science

Shanghai Pharmas Form Union to Fix Short Supply of Drugs for Rare Diseases

Jul 20, 2018

Life Science

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Green World upgrades to OTCQX Best Markets

Jul 20, 2018

Life Science

Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal

Jul 19, 2018

Life Science

Shuwen Biotech’s Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit

Jul 19, 2018

Life Science

Tianjin Tasly in $24 Million Deal for EA Pharma Kidney Disease Drug

Jul 19, 2018

Life Science

Ascletis’ Hong Kong IPO to Raise $457 Million at $2 Billion Valuation

Jul 19, 2018

Life Science

Maple Leaf Green World Inc TSXV:MGW Agriculture, Biotechnology, Consumer Products and Services, Cannabis, 农业,生物科技,消费品,大麻

Maple Leaf Enters into Non-Binding Memorandum of Understanding with High Tide Ventures Inc.

Jul 19, 2018

Life Science

NAI Life Science & Tech - www.nai500.com

Life Science & Technology Weekly 152 – China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing

Jul 19, 2018

Cannabis, Life Science

  • ‹‹ Previous
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada